Abstract
Introduction
To characterize quick contrast sensitivity function (qCSF) in keratoconus and its correlation with corneal topographic parameters.
Methods
Patients with keratoconus (n = 120) who visited the Fudan Eye and ENT Hospital between April and June 2021 were enrolled in our study. A total of 215 eyes were subdivided into three groups according to maximum keratometry (Kmax): Group 1 (Kmax ≤ 48 D, 74 eyes), Group 2 (48 D < Kmax ≤ 55 D, 64 eyes), and Group 3 (Kmax > 55 D, 77 eyes). Manifest refraction, best corrected distance visual acuity (BCVA), corneal topography, and the qCSF test were examined. Intergroup comparisons and correlations among various corneal topographic parameters and qCSF were analyzed.
Results
Significant differences in the area under the log CSF (AULCSF) and CSF Acuity among the three groups were found, which decreased with an increase in Kmax. Contrast sensitivity (CS) between spatial frequencies of 3.0 to 18.0 cpd was significantly different (all P < 0.05) between Groups 1 and 2. The CS at all spatial frequencies was significantly different (all P < 0.05) between Group 3 and other two groups. At 3.0–18.0 cpd, CS decreased significantly (all P < 0.05) in Groups 1–3. Manifest refraction and topographic indices correlated significantly with qCSF parameters (all P < 0.05). Multivariable linear regression analysis showed that cylindrical refraction, logMAR BCVA, and index of surface variance had good predictive values for AULCSF and CSF Acuity.
Conclusions
The use of qCSF test can serve as a feasible tool to evaluate visual quality and severity of keratoconus, since changes in CS significantly correlated with keratoconus severity.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Why carry out this study? | |
Keratoconus is a corneal ectatic disease characterized by decreased corneal thickness, corneal protrusion, and increased irregular astigmatism. | |
Visual acuity and manifest refraction are insufficient to reflect the visual quality of keratoconus. | |
The quick contrast sensitivity function (qCSF) test can comprehensively evaluate different contrast sensitivities under a series of spatial frequencies. | |
What was learned from the study? | |
The changes of contrast sensitivity were significantly correlated with the severity of keratoconus. | |
The qCSF test can serve as a feasible tool to evaluate the visual quality and severity of keratoconus. |
Introduction
Keratoconus (KC) is a corneal ectatic disease characterized by decreased corneal thickness, corneal protrusion, and increased irregular astigmatism, resulting in corneal edema, and scarring at the late stage. The prevalence of keratoconus is approximately 1 in 2000 patients, who can suffer from irreversible damage of visual function [1]. In early keratoconus, photokeratoscopy or corneal topography can be used to detect abnormal corneal morphology, including increased corneal curvature, front and back elevations, and irregular astigmatism [2].
Visual acuity (VA) is the most commonly used and basic index to evaluate ophthalmic disease; however, it merely represents the best spatial frequencies that humans can distinguish under high contrast ratio, which is insufficient to assess the spatial visual function of the human eye and reflect the patients’ subjective perception. For example, some patients with early keratoconus may complain of visual blur or distortion, yet their best corrected distance visual acuity (BCVA) can remain normal. In fact, their visual function cannot meet the needs of daily life, and manifest refraction outcomes may fluctuate significantly because of irregular corneal astigmatism.
The contrast sensitivity (CS) test can comprehensively evaluate the ability of the human eye to distinguish between different contrast ratios under a series of spatial frequencies. The quick contrast sensitivity function (qCSF) test is a novel method developed by Lesmes et al. [3] for assessing CS. Compared to conventional methods such as the Pelli–Robson chart and CVS-1000 series chart, the qCSF test utilizes the Bayesian adaptive test strategy as the optimization algorithm and the 10-digit identification task to obtain a faster testing speed, good accuracy, and high test–retest reliability that has been clinically validated [4,5,6].
We believe that evaluating the visual quality of keratoconus with qCSF parameters would theoretically be more accurate and objective. To date, the application of qCSF in keratoconus has not been reported, and the distribution characteristics of qCSF in keratoconus are unclear. Moreover, the correlation between CS of keratoconus and commonly used methods, such as VA and corneal topography, is worth studying. Therefore, this study aimed to explore the characteristics of qCSF and analyze the relationship between qCSF and the corneal topographic features of keratoconus, thus providing new perspectives for monitoring the progress of keratoconus and therapeutic strategies in clinical practice.
Methods
Patients
This cross-sectional study was conducted in accordance with the Declaration of Helsinki and was approved by the ethics committee of the Eye and ENT Hospital of Fudan University (ky2012-017). Informed consent was obtained from all patients.
The inclusion criterion was diagnosis of keratoconus without corneal cross-linking or keratoplasty.
Exclusion criteria were history of other eye diseases (such as glaucoma, cataract, and macular degeneration), history of eye surgery, history of systemic diseases (such as hypertension, diabetes, and connective tissue disease), pregnancy, and inability to cooperate with the examination.
This study included consecutive patients with keratoconus who visited the Eye and ENT Hospital of Fudan University from April to June 2021. Keratoconus eyes of the included participants were classified into three groups according to the maximum curvature of the anterior corneal surface (Kmax): Group 1 (Kmax ≤ 48 D), Group 2 (48 D < Kmax ≤ 55 D), and Group 3 (Kmax > 55 D).
Examinations
The following examinations were performed and parameters were assessed: (1) subjective refraction: the patient’s spherical diopter, cylindrical diopter, cylindrical axis, and BCVA were examined by an experienced optometrist; (2) corneal topography by the Pentacam HR (Oculus Optikgerate Wetzlar, Germany) was used to assess the following: flat keratometry (K1), steep keratometry (K2), mean keratometry (Kmean), Kmax of the anterior corneal surface, the index of surface variance (ISV), index of vertical asymmetry (IVA), keratoconus index (KI), central keratoconus index (CKI), index of highest asymmetry (IHA), index of highest dencentralization (IHD), minimum sagittal curvature (RsagMin), thinnest pachymetry (TCT), front elevation of the thinnest point (FETh), and back elevation of the thinnest point (BETh).
Contrast Sensitivity Test
The qCSF test was conducted in a mesopic environment at a test distance of 3 m while the participants wore spectacles for the best distance correction. The display used in the test was an NEC P403 monitor (Gension & Waltai Digital Video System Co. Ltd. China), size 116.84 × 77.89 cm, resolution 1920 × 1080 pixels, maximum brightness 700 cd/m2. The standard brightness in the test was 550 cd/m2 and the contrast ratio was 4000:1. Ten digits filtered by a raised cosine filter were used as the test stimuli in a 10-alternative forced choice identification task (10AFC) [6, 7], and the spatial frequencies were between 1.4 and 36.2 cpd. In each trial, three filtered digits of the same size but of successively lower contrast ratios were displayed on the screen; the participants were required to report the number they saw or that they could not see it clearly. The technician then entered the corresponding results on a tablet computer. Only one eye was tested at a time and the contralateral eye was covered with an eye patch. After 25 trials, the area under log CSF (AULCSF), cutoff spatial frequencies (CSF Acuity), and log contrast sensitivity (log CS) at spatial frequencies of 1.0, 1.5, 3.0, 6.0, 12.0, and 18.0 cpd would be automatically calculated by the software.
Statistical Analysis
Statistical Package for the Social Sciences (SPSS v26.0, IBM Corp., Armonk, NY, USA) was used for statistical analysis. Descriptive analysis (mean ± standard error) was used to display the baseline and qCSF values for the different groups. To adjust for interocular correlation, the generalized estimating equation (GEE) models were used to test the differences in baseline parameters and qCSF among the three groups, and to examine the differences among all qCSF values for each group, in which the sequential Šidák was the post hoc test. Pearson’s correlations were used to determine the relationship between qCSF values and other variables. Multivariable linear regression with the forward stepwise method was used to predict the qCSF parameters, and variables with P > 0.1 were excluded.
Results
Demographic Data
Participants’ age, subjective refraction, BCVA, and corneal topographic parameters are shown in Table 1. This study included 215 keratoconus eyes of 120 patients (average age 23.22 ± 6.67 years, range 8–41 years), with 74 eyes in Group 1 (Kmax ≤ 48 D), 64 eyes in Group 2 (48 D < Kmax ≤ 55 D), and 77 eyes in Group 3 (Kmax > 55 D). Except for age, the other parameters were significantly different among the three groups (P < 0.01).
Characteristics of qCSF Distribution
Table 2 shows the qCSF results for the three groups. There were significant differences in AULCSF and CSF Acuity among the three groups (P < 0.001), the values of which decreased with the severity of keratoconus (Fig. 1a, b).
Intergroup comparison (Table 2) showed that the CS at low spatial frequencies (1.0 and 1.5 cpd) was significantly lower in severe keratoconus (Group 3) than in mild and moderate keratoconus (Group 1, Group 2) (P < 0.05). The CS at medium and high spatial frequencies (3.0–18.0 cpd) decreased with the severity of keratoconus (P < 0.05).
Intragroup comparisons (Fig. 1c) revealed that CS showed a downward trend with an increase in spatial frequency, in which CS of the three groups decreased significantly from 3.0 cpd (all P < 0.05). In severe keratoconus (Group 3), CS at 12.0 cpd was not significantly different from that at 18.0 cpd (P > 0.05).
Correlation Analysis
Correlation analysis between various parameters is represented in Table 3. There was no correlation between age and qCSF parameters (P > 0.05), nor between IHA and CS at 18.0 cpd (P > 0.05). Other parameters were significantly correlated with qCSF parameters (P < 0.05). Figure 2 shows the correlations between the various parameters and qCSF.
Multivariable Linear Regression Analysis
Table 4 shows the predictors of qCSF parameters analyzed using multivariable linear regression. In terms of predicting AULCSF and CSF Acuity, the regression equation composed of Cyl, logMAR BCVA, and ISV obtained an adjusted R2 of 0.585 and 0.529, respectively. The results showed that BCVA and irregularity of the cornea had a relatively strong predictive value for qCSF. However, the goodness of fit was low in predicting CS at 12.0 and 18.0 cpd (adjusted R2 = 0.311 and 0.104).
Discussion
Keratoconus can cause irregular corneal astigmatism and impair visual function. Although some patients with keratoconus may have a normal BCVA, some still complain of blurred vision, indicating that the abnormal visual performance of keratoconus requires a more comprehensive and accurate evaluation. In 2010, Lesmes et al. introduced the qCSF method [3]. Traditional CS tests, such as the Pelli–Robson chart, use coarse quantization and sampling, and are limited to a fixed spatial frequency [8], while the qCSF test can identify and measure disproportionate reductions in CS at specific spatial frequencies through depicting a complete CSF curve. The qCSF has been applied to measure CSF in several clinical populations, including amblyopia [9], multiple sclerosis [10], glaucoma [11], early diabetic retinopathy [12], and aging [13] with great test–retest reliability and high sensitivity in detecting subtle changes in visual function [4, 5]. The present study is the first to report on qCSF in keratoconus.
Early screening and assessment of visual abnormalities in keratoconus are important for detecting the progression of keratoconus and making therapeutic decisions. This study showed that AULCSF and CSF Acuity significantly decreased with keratoconus severity. Our findings showed that the decrease in CS was significantly correlated with an increase in irregular corneal astigmatism in keratoconus. The BCVA also decreased with the severity of keratoconus, which was consistent with AULCSF and CSF Acuity. In clinical practice, VA is currently considered the gold standard for evaluating the visual function of patients, and ophthalmologists routinely examine the patient’s subjective refraction to evaluate the impact of keratoconus on visual function. However, with an increase in disease severity, irregular corneal astigmatism leads to increased examination time and decreased credibility of the VA test, as it is difficult for patients to recognize optotypes. Therefore, VA may not be ideal for assessing patients with keratoconus. Previous studies indicated that CS seems to correlate better with subjective visual impairment and vision-related quality of life compared to VA [14,15,16,17], and may detect more subtle changes in visual function [14]. The time for test completion is 2–5 min per eye [3], which is easy for patients to cooperate with. Thus, qCSF may be a promising visual function endpoint for patients with keratoconus.
The qCSF test presents patients with spatially filtered optotypes that modify both spatial frequency and contrast, in order to efficiently estimate CSF across multiple spatial frequencies in parallel [18]. Patients may have CSF impairments even when their VA seems normal, suggesting that the CSF is more sensitive than letter acuity in identifying spatial vision deficits [19]. This study showed that the CS at low spatial frequencies (1.0 and 1.5 cpd) was not significantly different between mild and moderate keratoconus, but that of the two groups was significantly different from that of severe keratoconus. The CS at medium and high spatial frequencies (3.0–18.0 cpd) was significantly different among the three groups (Table 2). The results indicated that the severity of keratoconus could be detected by CS at different spatial frequencies, and that the impairment of CS at a lower spatial frequency suggests a more severe stage of keratoconus. In patients with the same BCVA or unreliable visual outcomes, CS at different spatial frequencies through the qCSF test can help identify the impact of keratoconus on visual functions.
Furthermore, the results of this study showed that the CS in the three groups of keratoconus decreased significantly by 3.0 cpd (Fig. 1c). In normal eyes, the CS appeared to decrease significantly by 6.0 cpd [12, 13], which was different from that in keratoconus as shown in our study. A previous study showed that a CS threshold of 6.0 cpd was closely correlated with patient’s ability to identify traffic signs and objects, reflecting the visual function in daily life [3]. When compared to VA, the CSF appears to have a better correlation with everyday activities, like mobility [20], target and face recognition [21], driving [22], walking [23], and reading [24]; and subjectively perceived visual impairment [25]. This study indicated that even in patients with mild keratoconus and relatively good BCVA, the damaged visual functions would significantly affect activities of daily living. Thus, this study provides clues regarding the importance of early diagnosis and intensive monitoring of keratoconus. And the qCSF test would be a more valuable addition to the guidelines for clinical judgement on initiating and evaluating therapeutic interventions, especially in early keratoconus with an apparent decrease in VA yet impaired visual function.
This study showed that topographical indices were correlated with qCSF parameters; ISV, IVA, KI, CKI, IHA, and IHD were negatively correlated, and RSagMin was positively correlated with qCSF parameters, which indicated that qCSF parameters decreased with corneal irregularity. This proves that qCSF is closely correlated with corneal morphological changes and the development of keratoconus, and qCSF could also be applied to evaluate the clinical outcomes and visual quality after corneal collagen cross-linking (CXL). It has been reported that the steepness and irregularity of corneas would decrease after CXL, while there may be no significant changes in the corneal curvature or VA, especially after transepithelial CXL [26, 27]. Therefore, researchers are still looking for a more sensitive index that can better reflect the effect of CXL. Previous studies have shown qCSF to be highly sensitive [4], and our findings indicate that it is highly correlated with ISV and IHD. Hence, we assume that the qCSF parameters may be improved when corneal irregularity decreases after CXL. Future studies are needed to clarify this assumption.
Additionally, our findings show that the correlation between IHA and qCSF was weaker than that between ISV, IVA, KI, and CKI. Possible reasons may be the relatively low sensitivity and specificity of IHA for classifying keratoconus [28, 29]; thus, the intergroup differences of IHA were less than those of other topographic indices. In this study, manifest refraction positively correlated with qCSF; the closer the refractive error is to emmetropia, the larger the qCSF parameter, which also indicates a correlation between CS and disease severity. However, the degree of correlation between refraction and qCSF was less than that of corneal asymmetric indices, which may be due to the influence of corneal irregular astigmatism and optometric errors on the accuracy of subjective refraction in patients with keratoconus.
In the multivariable linear regressions, the cylindrical refraction, BCVA, and ISV were the major predictors for qCSF parameters (Table 4). The ISV is the standard deviation of the axial radii of the eye from the mean anterior corneal curvature, and represents the irregularity of anterior corneal curvature [30]. Our findings manifested the significant influence of corneal irregularity on visual function, which was in accordance with previous studies [31, 32]. However, the correlations between CS at high spatial frequencies (12.0 and 18.0 cpd) and other parameters were relatively weak (Table 3) and the goodness of fit of corresponding regression models was low (Table 4). The reason may be that it was difficult for patients to recognize the visual stimuli at high spatial frequencies because of visual impairments. Therefore, the CS at low and medium spatial frequencies (1.0–6.0 cpd) would be more accurate and valuable in assessing the visual function in keratoconus. Besides, the axial length, which may influence contrast sensitivity function [33], was not included as a parameter in the study. However, the correlation between axial length and severity of keratoconus was insignificant as reported by previous studies [34, 35], and thus it may not have a significant impact on the multivariable regression models for qCSF parameters. Overall, our findings indicate that the qCSF parameters, which reflect both visual acuity and corneal irregularity, are an appropriate indicator of visual function in keratoconus.
This study had some limitations. First, the sample size was small, which may have affected statistical efficacy. Therefore, we will continue to enroll more patients for further analysis. Second, this study compared the qCSF characteristics of patients with different degrees of keratoconus but did not include a normal control group. Compared with previous studies in the normal population, qCSF seemed to decrease in keratoconus [10, 36]. However, it cannot be compared directly as contrast sensitivity is correlated with age and refraction [13, 37]. Normal controls should be included in further studies to confirm changes in qCSF in keratoconus at early stage and provide reference to the clinical application of qCSF test in screening keratoconus.
Conclusion
This study shows that changes in contrast sensitivity in keratoconus are significantly correlated with disease severity, and qCSF can serve as a feasible tool to assess the visual quality and severity of keratoconus.
References
Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42:297–319.
Santodomingo-Rubido J, Carracedo G, Suzaki A, Villa-Collar C, Vincent SJ, Wolffsohn JS. Keratoconus: an updated review. Cont Lens Anterior Eye. 2022;45: 101559.
Lesmes LA, Lu Z-L, Baek J, Albright TD. Bayesian adaptive estimation of the contrast sensitivity function: the quick CSF method. J Vis. 2010;10:17.1–21.
Chen Z, Zhuang Y, Xu Z, et al. Sensitivity and stability of functional vision tests in detecting subtle changes under multiple simulated conditions. Transl Vis Sci Technol. 2021;10:7.
Hou F, Lesmes LA, Kim W, et al. Evaluating the performance of the quick CSF method in detecting contrast sensitivity function changes. J Vis. 2016;16:18.
Zheng H, Shen M, He X, et al. Comparing spatial contrast sensitivity functions measured with digit and grating stimuli. Transl Vis Sci Technol. 2019;8:16.
Zheng H, Wang C, Cui R, et al. Measuring the contrast sensitivity function using the qCSF method with 10 digits. Trans Vis Sci Tech. 2018;7:9.
Thayaparan K, Crossland MD, Rubin GS. Clinical assessment of two new contrast sensitivity charts. Br J Ophthalmol. 2007;91:749–52.
Hou F, Huang C-B, Lesmes L, et al. qCSF in clinical application: efficient characterization and classification of contrast sensitivity functions in amblyopia. Invest Ophthalmol Vis Sci. 2010;51:5365–77.
Rosenkranz SC, Kaulen B, Zimmermann HG, Bittner AK, Dorr M, Stellmann J-P. Validation of computer-adaptive contrast sensitivity as a tool to assess visual impairment in multiple sclerosis patients. Front Neurosci. 2021;15: 591302.
Lin S, Mihailovic A, West SK, et al. Predicting visual disability in glaucoma with combinations of vision measures. Transl Vis Sci Technol. 2018;7:22.
Joltikov KA, de Castro VM, Davila JR, et al. Multidimensional functional and structural evaluation reveals neuroretinal impairment in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 2017;58:BIO277–90.
Li Z, Hu Y, Yu H, Li J, Yang X. Effect of age and refractive error on quick contrast sensitivity function in Chinese adults: a pilot study. Eye (Lond). 2021;35:966–72.
Pondorfer SG, Terheyden JH, Heinemann M, Wintergerst MWM, Holz FG, Finger RP. Association of vision-related quality of life with visual function in age-related macular degeneration. Sci Rep. 2019;9:15326.
Ivers RQ, Mitchell P, Cumming RG. Visual function tests, eye disease and symptoms of visual disability: a population-based assessment. Clin Exp Ophthalmol. 2000;28:41–7.
Rubin GS, Bandeen-Roche K, Huang GH, et al. The association of multiple visual impairments with self-reported visual disability: SEE project. Invest Ophthalmol Vis Sci. 2001;42:64–72.
Lennerstrand G, Ahlström CO. Contrast sensitivity in macular degeneration and the relation to subjective visual impairment. Acta Ophthalmol (Copenh). 1989;67:225–33.
Dorr M, Wille M, Viulet T, et al. Next-generation vision testing: the quick CSF. Curr Dir Biomed Eng. 2015;1:131–4.
Plainis S, Anastasakis AG, Tsilimbaris MK. The value of contrast sensitivity in diagnosing central serous chorioretinopathy. Clin Exp Optom. 2007;90:296–8.
Marron JA, Bailey IL. Visual factors and orientation-mobility performance. Am J Optom Physiol Opt. 1982;59:413–26.
Owsley C, Sloane ME. Contrast sensitivity, acuity, and the perception of “real-world” targets. Br J Ophthalmol. 1987;71:791–6.
Owsley C, McGwin G. Vision and driving. Vis Res. 2010;50:2348–61.
Geruschat DR, Turano KA, Stahl JW. Traditional measures of mobility performance and retinitis pigmentosa. Optom Vis Sci. 1998;75:525–37.
Owsley C. Contrast sensitivity. Ophthalmol Clin North Am. 2003;16:171–7.
West SK, Rubin GS, Broman AT, Muñoz B, Bandeen-Roche K, Turano K. How does visual impairment affect performance on tasks of everyday life? The SEE Project. Salisbury Eye Evaluation. Arch Ophthalmol. 2002;120:774–80.
Chen S, Chan TCY, Zhang J, et al. Epithelium-on corneal collagen crosslinking for management of advanced keratoconus. J Cataract Refract Surg. 2016;42:738–49.
Sun L, Li M, Zhang X, et al. Transepithelial accelerated corneal collagen cross-linking with higher oxygen availability for keratoconus: 1-year results. Int Ophthalmol. 2018;38:2509–17.
Shetty R, Rao H, Khamar P, et al. Keratoconus screening indices and their diagnostic ability to distinguish normal from ectatic corneas. Am J Ophthalmol. 2017;181:140–8.
Uçakhan ÖÖ, Cetinkor V, Özkan M, Kanpolat A. Evaluation of Scheimpflug imaging parameters in subclinical keratoconus, keratoconus, and normal eyes. J Cataract Refract Surg. 2011;37:1116–24.
Utine CA, Durmaz Engin C, Ayhan Z. Effects of preoperative topometric indices on visual gain after intracorneal ring segment implantation for keratoconus. Eye Contact Lens. 2018;44(Suppl 2):S387–91.
Shneor E, Piñero DP, Doron R. Contrast sensitivity and higher-order aberrations in keratoconus subjects. Sci Rep. 2021;11:12971.
Okamoto C, Okamoto F, Samejima T, Miyata K, Oshika T. Higher-order wavefront aberration and letter-contrast sensitivity in keratoconus. Eye. 2008;22:1488–92.
Liu X, Wang Y, Ying X, et al. Contrast sensitivity is associated with chorioretinal thickness and vascular density of eyes in simple early-stage high myopia. Front Med (Lausanne). 2022;9: 847817.
Sahebjada S, Xie J, Chan E, Snibson G, Daniel M, Baird PN. Assessment of anterior segment parameters of keratoconus eyes in an Australian population. Optom Vis Sci. 2014;91:803–9.
Ernst BJ, Hsu HY. Keratoconus association with axial myopia: a prospective biometric study. Eye Contact Lens. 2011;37:2–5.
Stellmann JP, Young KL, Pöttgen J, Dorr M, Heesen C. Introducing a new method to assess vision: computer-adaptive contrast-sensitivity testing predicts visual functioning better than charts in multiple sclerosis patients. Mult Scler J Exp Transl Clin. 2015;1:2055217315596184.
Hashemi H, Khabazkhoob M, Jafarzadehpur E, Emamian MH, Shariati M, Fotouhi A. Contrast sensitivity evaluation in a population-based study in Shahroud. Iran Ophthalmol. 2012;119:541–6.
Acknowledgements
Funding
National Natural Science Foundation of China (Grant No. 82271119), Project of Shanghai Science and Technology (Grant No. 21Y11909800) (Grant No.20410710100), Clinical Research Plan of SHDC (SHDC2020CR1043B), Project of Shanghai Xuhui District Science and Technology (XHLHGG202104), Healthy Young Talents Project of Shanghai Municipal Health Commission (2022YQ015). Jing Zhao is funding the journal’s Rapid Service fees.
Editorial Assistance
We would like to thank Editage (www.editage.cn) for English language editing.
Author Contributions
Study concept and design (Yiyong Xian, Ling Sun, Xingtao Zhou, Jing Zhao); data collection (Yiyong Xian, Ling Sun, Yuhao Ye, Xiaoyu Zhang, Wuxiao Zhao, Yang Shen); data analysis and interpretation (Yiyong Xian, Ling Sun, Jing Zhao); drafting of the manuscript (Yiyong Xian, Ling Sun, Jing Zhao); provide materials (Zhong-lin Lu); critical revision of the manuscript (Yiyong Xian, Ling Sun, Jing Zhao, Xingtao Zhou); supervision (Jing Zhao, Xingtao Zhou). All authors read and approved the final manuscript.
Disclosures
The sponsor or funding organization had no role in the design or conduct of this research. Yiyong Xian, Ling Sun, Yuhao Ye, Xiaoyu Zhang, Wuxiao Zhao, Yang Shen, Xingtao Zhou, and Jing Zhao have nothing to disclose. Zhong-lin Lu holds intellectual property interests in visual function measurement and rehabilitation technologies and equity interests in Adaptive Sensory Technology, Inc. (San Diego, CA) and Juehua Medical Technology, Ltd (Beijing, China).
Compliance with Ethics Guidelines
This study was carried out in accordance with the recommendations of tenets of the Declaration of Helsinki with written informed consent from all subjects. All subjects gave written informed consent in accordance with the Declaration of Helsinki. The protocol was approved by the Ethics Committee of Fudan University Eye and ENT Hospital Review Board (Shanghai, China) (ky2012-017).
Data Availability
The datasets generated and/or analyzed during the current study are not publicly available due to funding requirement but are available from the corresponding author on reasonable request.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Xian, Y., Sun, L., Ye, Y. et al. The Characteristics of Quick Contrast Sensitivity Function in Keratoconus and Its Correlation with Corneal Topography. Ophthalmol Ther 12, 293–305 (2023). https://doi.org/10.1007/s40123-022-00609-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40123-022-00609-5